Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-0711
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication ; volume:17 ; number:1 ; day:28 ; month:6 ; year:2018 ; pages:1-7 ; date:12.2018
Annals of clinical microbiology and antimicrobials ; 17, Heft 1 (28.6.2018), 1-7, 12.2018
- Urheber
-
Tanabe, Hiroki
- Beteiligte Personen und Organisationen
-
Yoshino, Keiichi
Ando, Katsuyoshi
Nomura, Yoshiki
Ohta, Katsuhisa
Satoh, Kiichi
Ichiishi, Eiichiro
Ishizuka, Akiei
Otake, Takaaki
Kohgo, Yutaka
Fujiya, Mikihiro
Okumura, Toshikatsu
SpringerLink (Online service)
- DOI
-
10.1186/s12941-018-0281-x
- URN
-
urn:nbn:de:101:1-2018082518554046939513
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tanabe, Hiroki
- Yoshino, Keiichi
- Ando, Katsuyoshi
- Nomura, Yoshiki
- Ohta, Katsuhisa
- Satoh, Kiichi
- Ichiishi, Eiichiro
- Ishizuka, Akiei
- Otake, Takaaki
- Kohgo, Yutaka
- Fujiya, Mikihiro
- Okumura, Toshikatsu
- SpringerLink (Online service)
Ähnliche Objekte (12)
Triple artemisinin-based combination therapy (TACT): advancing malaria control and eradication efforts
Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication
Evaluation of Helicobacter Pylori eradication in pediatric patients by triple therapy plus lactoferrin and probiotics compared to triple therapy alone
Triple therapy for Helicobacter pylori eradication and the risk of hypoglycemia in patients with diabetes: a population-based cohort study
A randomized trial of everolimus‐based quadruple therapy vs standard triple therapy early after lung transplantation
Saccharomyces boulardii combined with triple therapy alter the microbiota in the eradication of Helicobacter pylori infection
Efficacy analysis of empirical bismuth quadruple therapy, high-dose dual therapy, and resistance gene-based triple therapy as a first-line Helicobacter pylori eradication regimen – An open-label, randomized trial
Strategies for deploying triple artemisinin-based combination therapy in the Greater Mekong Subregion
Short-term triple therapy with azithromycin for Helicobacter pylori eradication: Low cost, high compliance, but low efficacy
A comparison between conventional triple therapy and sequential therapy on tolerance of treatment and eradication of Helicobacter pylori infection in Egyptian patients
New Vaccine Therapy for Triple-Negative Breast Cancer
Auger emitter based endogenous therapy with an Olaparib derivative in triple negative breast cancer
Triple artemisinin-based combination therapy (TACT): advancing malaria control and eradication efforts
Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication
Evaluation of Helicobacter Pylori eradication in pediatric patients by triple therapy plus lactoferrin and probiotics compared to triple therapy alone
Triple therapy for Helicobacter pylori eradication and the risk of hypoglycemia in patients with diabetes: a population-based cohort study
A randomized trial of everolimus‐based quadruple therapy vs standard triple therapy early after lung transplantation
Saccharomyces boulardii combined with triple therapy alter the microbiota in the eradication of Helicobacter pylori infection
Efficacy analysis of empirical bismuth quadruple therapy, high-dose dual therapy, and resistance gene-based triple therapy as a first-line Helicobacter pylori eradication regimen – An open-label, randomized trial
Strategies for deploying triple artemisinin-based combination therapy in the Greater Mekong Subregion
Short-term triple therapy with azithromycin for Helicobacter pylori eradication: Low cost, high compliance, but low efficacy
A comparison between conventional triple therapy and sequential therapy on tolerance of treatment and eradication of Helicobacter pylori infection in Egyptian patients
New Vaccine Therapy for Triple-Negative Breast Cancer
Auger emitter based endogenous therapy with an Olaparib derivative in triple negative breast cancer
Triple artemisinin-based combination therapy (TACT): advancing malaria control and eradication efforts
Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication
Evaluation of Helicobacter Pylori eradication in pediatric patients by triple therapy plus lactoferrin and probiotics compared to triple therapy alone
Triple therapy for Helicobacter pylori eradication and the risk of hypoglycemia in patients with diabetes: a population-based cohort study
A randomized trial of everolimus‐based quadruple therapy vs standard triple therapy early after lung transplantation
Saccharomyces boulardii combined with triple therapy alter the microbiota in the eradication of Helicobacter pylori infection
Efficacy analysis of empirical bismuth quadruple therapy, high-dose dual therapy, and resistance gene-based triple therapy as a first-line Helicobacter pylori eradication regimen – An open-label, randomized trial
Strategies for deploying triple artemisinin-based combination therapy in the Greater Mekong Subregion
Short-term triple therapy with azithromycin for Helicobacter pylori eradication: Low cost, high compliance, but low efficacy
A comparison between conventional triple therapy and sequential therapy on tolerance of treatment and eradication of Helicobacter pylori infection in Egyptian patients
New Vaccine Therapy for Triple-Negative Breast Cancer